Key Financial Data Of Group

Noile-Immune Biotech Inc. - Filing #7270247

Concept As at
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
Key financial data of group
Business results of group
Ordinary profit (loss)
-962,035,000 JPY
-1,127,594,000 JPY
-384,202,000 JPY
-792,615,000 JPY
-604,610,000 JPY
Net assets
4,725,497,000 JPY
5,687,452,000 JPY
4,300,617,000 JPY
4,185,334,000 JPY
2,598,379,000 JPY
Total assets
4,800,172,000 JPY
5,778,946,000 JPY
4,641,032,000 JPY
4,271,049,000 JPY
2,674,261,000 JPY
Net assets per share
108.97
131.26
108.48
107.30
361.19
Basic earnings (loss) per share
-22.28
-27.25
-9.87
-20.75
-89.64
Diluted earnings per share
Equity-to-asset ratio
0.983 xbrli:pure
0.983 xbrli:pure
0.925 xbrli:pure
0.979 xbrli:pure
0.970 xbrli:pure
Rate of return on equity
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Price-earnings ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Net cash provided by (used in) operating activities
-887,809,000 JPY
-873,076,000 JPY
-107,176,000 JPY
-777,140,000 JPY
-300,645,000 JPY
Net cash provided by (used in) investing activities
557,000 JPY
-5,316,000 JPY
JPY
-4,032,000 JPY
JPY
Net cash provided by (used in) financing activities
2,500,000 JPY
1,913,086,000 JPY
487,615,000 JPY
2,373,653,000 JPY
996,346,000 JPY
Cash and cash equivalents
4,670,939,000 JPY
5,555,691,000 JPY
4,520,997,000 JPY
4,140,558,000 JPY
2,548,077,000 JPY
Number of employees
25 xbrli:pure
28 xbrli:pure
19 xbrli:pure
14 xbrli:pure
12 xbrli:pure
Average number of temporary employees
4 xbrli:pure
5 xbrli:pure
6 xbrli:pure
5 xbrli:pure
5 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.